248 related articles for article (PubMed ID: 33706683)
1. Potential inhibitors of angiotensin converting enzyme 2 receptor of COVID-19 by
Mesli F; Ghalem M; Daoud I; Ghalem S
J Biomol Struct Dyn; 2022 Oct; 40(16):7311-7323. PubMed ID: 33706683
[TBL] [Abstract][Full Text] [Related]
2.
Abdelli I; Hassani F; Bekkel Brikci S; Ghalem S
J Biomol Struct Dyn; 2021 Jun; 39(9):3263-3276. PubMed ID: 32362217
[TBL] [Abstract][Full Text] [Related]
3. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
4. Repurposing of anticancer phytochemicals for identifying potential fusion inhibitor for SARS-CoV-2 using molecular docking and molecular dynamics (MD) simulations.
Patel CN; Goswami D; Sivakumar PK; Pandya HA
J Biomol Struct Dyn; 2022 Oct; 40(17):7744-7761. PubMed ID: 33749528
[TBL] [Abstract][Full Text] [Related]
5. Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study.
Al-Shuhaib MBS; Hashim HO; Al-Shuhaib JMB
Comput Biol Med; 2022 Feb; 141():105155. PubMed ID: 34942397
[TBL] [Abstract][Full Text] [Related]
6. Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease.
Oso BJ; Olaoye IF; Omeike SO
Arch Razi Inst; 2021; 76(3):453-459. PubMed ID: 34824739
[TBL] [Abstract][Full Text] [Related]
7. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
8. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
9. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.
Vardhan S; Sahoo SK
Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628
[TBL] [Abstract][Full Text] [Related]
10. Polyphenolic compounds with anti-tumour potential from Corchorus olitorius (L.) Tiliaceae, a Nigerian leaf vegetable.
Taiwo BJ; Taiwo GO; Olubiyi OO; Fatokun AA
Bioorg Med Chem Lett; 2016 Aug; 26(15):3404-10. PubMed ID: 27381082
[TBL] [Abstract][Full Text] [Related]
11. Carnosine to Combat Novel Coronavirus (nCoV): Molecular Docking and Modeling to Cocrystallized Host Angiotensin-Converting Enzyme 2 (ACE2) and Viral Spike Protein.
Saadah LM; Deiab GIA; Al-Balas Q; Basheti IA
Molecules; 2020 Nov; 25(23):. PubMed ID: 33260592
[TBL] [Abstract][Full Text] [Related]
12. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
Abdizadeh R; Hadizadeh F; Abdizadeh T
Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study.
Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
Eur J Pharmacol; 2021 Apr; 896():173922. PubMed ID: 33539819
[TBL] [Abstract][Full Text] [Related]
14. Tinocordiside from
Balkrishna A; Pokhrel S; Varshney A
Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
[TBL] [Abstract][Full Text] [Related]
15. Traditional medicinal plants against replication, maturation and transmission targets of SARS-CoV-2: computational investigation.
Mondal P; Natesh J; Abdul Salam AA; Thiyagarajan S; Meeran SM
J Biomol Struct Dyn; 2022 Apr; 40(6):2715-2732. PubMed ID: 33150860
[TBL] [Abstract][Full Text] [Related]
16. In Silico Molecular Dynamics of Griseofulvin and Its Derivatives Revealed Potential Therapeutic Applications for COVID-19.
Aris P; Mohamadzadeh M; Wei Y; Xia X
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805893
[TBL] [Abstract][Full Text] [Related]
17. Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent.
Basit A; Ali T; Rehman SU
J Biomol Struct Dyn; 2021 Jul; 39(10):3605-3614. PubMed ID: 32396773
[TBL] [Abstract][Full Text] [Related]
18. Approach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study.
Celı K I; Onay-Besı Kcı A; Ayhan-Kilcigı L G
J Biomol Struct Dyn; 2021 Sep; 39(15):5792-5798. PubMed ID: 32677545
[TBL] [Abstract][Full Text] [Related]
19. De novo design of novel spike glycoprotein inhibitors using e-pharmacophore modeling, molecular hybridization, ADMET, quantum mechanics and molecular dynamics studies for COVID-19.
A Alzain A; Ismail A; Fadlelmola M; A Mohamed M; Mahjoub M; A Makki A; Elsaman T
Pak J Pharm Sci; 2022 Jan; 35(1(Supplementary)):313-321. PubMed ID: 35228193
[TBL] [Abstract][Full Text] [Related]
20. Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies.
Rajagopal K; Varakumar P; Aparna B; Byran G; Jupudi S
J Biomol Struct Dyn; 2021 Sep; 39(15):5551-5562. PubMed ID: 32720578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
